An autoinjector is a medical device specifically designed to deliver a steady dose of a specific, pharmaceutical drug directly into a patient’s intravenous system. The original injectors were originally designed to overcome the difficulty associated with manual administration of the syringe-based drug transfer device. In the past two decades, the development of autoinjector devices has dramatically improved. These devices now offer physicians more choices in delivering their medications into the body. There are now a number of different types of autoinjector pumps, each offering different benefits and ease of use.
Major players operating in the global auto-injectors market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2019, Becton, Dickinson and Company launched the BD Intevia 1mL two-step disposable auto-injector.
Request To Sample PDF Brochure: https://www.coherentmarketinsights.com/insight/request-sample/1035
Approval and launch of new products is expected to propel growth of the global auto-injectors market over the forecast period. For instance, in August 2019, Teva Pharmaceutical Industries Ltd. launched generic version of Mylan’s EpiPen for young children.
Moreover, high prevalence of MS is also expected to aid in growth of the market. For instance. according to data from (updated November 2018), the Multiple Sclerosis Trust, the prevalence of MS in England is around 90,500 or 164 per 100,000 and about 3,200 or 175 per 100,000 in Northern Ireland.
R&D of new products through partnership strategies is expected to offer lucrative growth opportunities for players in the global auto-injectors market. For instance, in October 2019, Haselmeier, a manufacturer of self-injection devices, partnered with Stevanato Group, a producer of glass primary packaging based in Italy, for development, manufacturing, and supply of the axis-D pen-injector in the therapeutic area of diabetes care.
The global auto-injectors market is estimated to account for US$ 2,338.2 Mn in 2018 in terms of value and is expected to reach US$ 7,894.6 Mn by the end of 2027.
Prefilled Auto-Injectors sub segment in the product type segment in global auto-injectors market was valued at US$ 1,904.1 Mn in 2018 and is expected to reach US$ 7,266.6 Mn by 2027 at a CAGR of 15.1% during the forecast period.
North America region held dominant position in the global auto-injectors market in 2018, accounting for 75.9% share in terms of value, followed by Europe.
Europe is expected to witness significant growth in the global auto-injectors market, owing to high incidence of diabetes. For instance, according to the International Diabetes Federation, 59,322,100 suffered from diabetes in Europe in 2019, and the number is expected to reach 68,121,400 in 2045.
Availability of alternatives such as nasal spray is expected to hinder growth of the market. For instance, in October 2019, Bryn Pharma, LLC reported that patients prefer bi-dose epinephrine nasal spray over Epipen auto injector. The company presented the related data at the American Academy of Pediatrics (AAP) National Conference & Exhibition.
Get PDF Brochure with Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/1035
Competitive Landscape
Major players operating in the global auto-injectors market include, Antares Pharma, Inc., Amgen Inc., Bayer AG, Becton, Dickinson and Company, Eli Lilly and Company, Janssen Global Services, LLC, Mylan N.V., Novartis International AG, Pfizer, Inc., and Sanofi,
Global Auto-Injectors Market: Key Development
Major players operating in the global auto-injectors market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2019, Walgreens, a pharmacy store chain, and Kaléo, a privately-held pharmaceutical company, announced AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector – the first and only epinephrine auto-injector approved by the U.S. FDA for infants and toddlers is available at Walgreens locations.
Global Auto-Injectors Market: Segmentation
On the basis of product type, the global auto-injectors market is segmented into:
- Prefilled Auto-Injectors
- Fillable Auto-Injectors
On the basis of disease indication, the global auto-injectors market is segmented into:
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others
On the basis of distribution channel, the global auto-injectors market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
On the basis of region, the global auto-injectors market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Reasons to Purchase this Report
• Current and future of global Auto-injectors market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
- Market Dynamics
- Global Auto-Injectors Market, By Product Type, 2017 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019–2027
- Segment Trends
- Prefilled Auto-Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Segment Trends
- Fillable Auto-Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Auto-Injectors Market, By Disease Indication, 2017 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019–2027
- Segment Trends
- Anaphylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Introduction
- Global Auto-Injectors Market, By End User, 2017 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019–2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Introduction
- Global Auto-Injectors Market, By Regions, 2017 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Janssen Global Services Llc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Antares Pharma, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Co.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Press Release: https://www.coherentmarketinsights.com/press-release/auto-injectors-market-2702
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837